Black Rock Inc. Akero Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,586,637 shares of AKRO stock, worth $303 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,586,637
Previous 4,892,616
14.19%
Holding current value
$303 Million
Previous $124 Million
6.05%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AKRO
# of Institutions
299Shares Held
91.4MCall Options Held
1.04MPut Options Held
372K-
Janus Henderson Group PLC London, X06.28MShares$340 Million0.14% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$311 Million9.63% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$297 Million3.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$245 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.25MShares$230 Million0.04% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.52B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...